Results 61 to 70 of about 352 (104)

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Romiplostim for the Treatment of Immune Thrombocytopenia: Spotlight on Patient Acceptability and Ease of Use

Patient Preference and Adherence, 2020
Megan M Gilbert, Amanda B Grimes, Taylor Olmsted Kim, Jenny M Despotovic Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine, Houston, TX, USACorrespondence: Megan M GilbertDepartment of Pediatrics, Section of Hematology ...
Gilbert MM, Grimes AB, Kim TO, Despotovic JM   +3 more
doaj  

Experimental Validation a Method for Assessing Neutralizing Antibodies of Romiplostim in Human Plasma

Разработка и регистрация лекарственных средств
Introduction. Romiplostim is an analogue of the fusion protein peptide of thrombopoietin (TPO), which increases platelet count by binding and activating the human thrombopoietin receptor (TPO-R).
A. N. Afanaseva, V. B. Saparova, I. E. Makarenko, T. A. Selmenskikh, D. V. Kurkin, A. L. Hohlov, R. V. Drai   +6 more
doaj   +1 more source

Romiplostim during pregnancy in refractory primary immune thrombocytopenia: Literature review and case series

Therapeutic Advances in Hematology
Primary immune thrombocytopenia (ITP) in pregnancy presents significant therapeutic challenges, particularly when refractory to standard treatments such as corticosteroids, intravenous immunoglobulin, and immunosuppressants.
Dina Weinstein Mezan, Efrat Shekel, Batia Roth, Yosef Kalish, Doron Kabiri   +4 more
doaj   +1 more source

Thrombopoietin Receptor Agonists for Chemotherapy-Induced Thrombocytopenia: A Systematic Review and Network Meta-Analysis

Journal of Clinical Question
Background: Chemotherapy-induced thrombocytopenia (CIT) can lead to chemotherapy delays, dose reductions, and the need for platelet transfusions. However, comparative evidence for thrombopoietin receptor agonists (TPO-RAs) is limited.
Yong-Mei Guo, Yan Zhao, Toshiyoshi Maeda, Nouhaila Ezzaoui, Chinwebudu M. Melford   +4 more
doaj   +1 more source

Use of Immunosuppression, Romiplostim, and Splenectomy to Achieve Remission in a British Shorthair Cat With Primary Immune‐Mediated Thrombocytopenia

Journal of Veterinary Internal Medicine
A 2‐year‐old female spayed British Shorthair cat was diagnosed with immune‐mediated thrombocytopenia (ITP) after presenting with a 3‐week history of gastrointestinal bleeding and anemia.
Josh M. Kennils, Helen E. Wilson
doaj   +1 more source

Romiplostim N01 accelerates platelet engraftment in autologousstem cell transplantation using non-cryopreserved peripheral blood stem cells for plasma cell neoplasms

Frontiers in Immunology
BackgroundDelayed platelet engraftment remains a major limitation of autologous stem cell transplantation (ASCT) for plasma-cell neoplasms. Romiplostim N01, a thrombopoietin receptor agonist, may enhance early megakaryocytic recovery, while the use of ...
Xianfu Sheng, Qijia Zheng, Jingjing Xiang, Nanxi Dong, Yuechao Zhao, Huijin Hu, Lili Qian, Wenbin Liu, Jianping Shen, Baodong Ye, Yu Zhang   +10 more
doaj   +1 more source

Efficacy and Safety of Romiplostim Versus Placebo in Immune Thrombocytopenia: A Systematic Review and Meta-Analysis

Clinical and Applied Thrombosis/Hemostasis
Background Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia and increased bleeding risk. Although first-line therapies such as corticosteroids and intravenous immunoglobulin provide initial benefit, many ...
Humayou Ahmed, Muhammad Saad Khan, Daniyal Zulfiqar, Kainat Mehmood, Kanza Farhan, Syed Ali Hassan, Fiza Shaikh, Umarah Lutuf, Aqsa, Aminath Waafira   +9 more
doaj   +1 more source

P142 | ROMIPLOSTIM AS A TREATMENT FOR CHEMOTHERAPY INDUCED THROMBOCYTOPENIA: THREE CASE REPORTS AND A LITERATURE REVIEW

Haematologica
Chemotherapy-induced thrombocytopenia (CIT) is a common hematologic complication of cancer treatment, characterized by decreased platelet counts due to the cytotoxic effects of chemotherapy on megakaryocytes.
G. Fornari, D. Cilloni, A. Ferrero, G. Valabrega   +3 more
doaj  

Some of the next articles are maybe not open access.

Related searches:

Romiplostim

Drugs, 2012
Katherine Lyseng-Williamson, Frampton James E, Lyseng-Williamson Katherine A   +2 more
exaly   +9 more sources